Related Experiment Video
Updated: May 6, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
Chronic Hepatitis B Genotype C Mouse Model with Persistent Covalently Closed Circular DNA
Deok-Hwa Seo1, Wonhee Hur2, Juhee Won3
1The Catholic University Liver Research Center, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
Insights
A new mouse model effectively replicates chronic Hepatitis B virus (HBV) infection, enabling study of HBV cccDNA persistence. This breakthrough aids research into therapies targeting the viral DNA reservoir.
Area of Science:
- Hepatology
- Virology
- Molecular Biology
Background:
- Chronic Hepatitis B virus (HBV) infection poses significant mortality risks due to cirrhosis and hepatocellular carcinoma (HCC).
- Covalently closed circular DNA (cccDNA) is a persistent viral DNA reservoir in hepatocytes, driving continuous HBV replication and treatment resistance.
- Existing animal models inadequately replicate cccDNA dynamics, hindering research into HBV pathogenesis and therapeutics.
Purpose of the Study:
- To develop and validate a novel mouse model for investigating Hepatitis B virus cccDNA formation and maintenance.
- To establish a platform for evaluating therapeutic strategies targeting the HBV cccDNA reservoir.
Main Methods:
- Infection of C57BL/6 mice with recombinant adeno-associated virus (rAAV) carrying a 1.3-overlength HBV genome (genotype C).
- Assessment of cccDNA levels and viral replication markers (HBsAg, HBeAg, HBV DNA) at various time points.
- Quantitative PCR (qPCR) with selective DNase treatment and Southern blot analysis for cccDNA detection.
Main Results:
- Successful establishment of a chronic HBV mouse model with persistent cccDNA expression in hepatocytes.
- Sustained elevation of serum HBsAg and HBeAg for up to 12 weeks with normal alanine transaminase (ALT) levels.
- Confirmation of HBV DNA expression and detection of cccDNA using qPCR and Southern blot analysis.
Conclusions:
- The rAAV-HBV1.3 mouse model effectively recapitulates key aspects of chronic HBV infection, including cccDNA persistence.
- This model serves as a valuable tool for studying long-term cccDNA maintenance and for preclinical testing of novel anti-HBV therapies targeting cccDNA.
Abstract:
Hepatitis B virus (HBV) can cause chronic infections, significantly increasing the risk of death from cirrhosis and hepatocellular carcinoma (HCC). A key player in chronic HBV infection is covalently closed circular DNA (cccDNA), a stable episomal form of viral DNA that acts as a persistent reservoir in infected hepatocytes and drives continuous viral replication. Despite the development of several animal models, few adequately replicate cccDNA formation and maintenance, limiting our understanding of its dynamics and the evaluation of potential therapeutic interventions targeting cccDNA. In this study, we aimed to develop a mouse model to investigate cccDNA formation and maintenance. We infected C57BL/6 mice with recombinant adeno-associated virus (rAAV) carrying a 1.3-overlength HBV genome (genotype C) and collected liver tissue at various time points to assess cccDNA levels and viral replication. Our results demonstrated the successful establishment of a chronic hepatitis B mouse model using rAAV-HBV1.3, which supported persistent HBV infection with sustained cccDNA expression in hepatocytes. Serum levels of HBsAg and HBeAg were elevated for up to 12 weeks, while alanine transaminase (ALT) levels remained within the normal range, indicating limited liver damage during this period. We confirmed HBV DNA expression in hepatocytes, and importantly, cccDNA was detected using qPCR after Plasmid-Safe ATP-Dependent DNase treatment, which selectively removes non-cccDNA forms. Additionally, Southern blot analysis confirmed the presence of cccDNA isolated using the Hirt extraction method. This established model provides a valuable platform for studying the long-term maintenance of cccDNA in chronic HBV infection and offers an important tool for testing novel therapeutic strategies aimed at targeting cccDNA.
More Related Videos
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
07:25Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019